Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Mouse Monoclonal (IgG2b) to Influenza Virus Influenza B Virus
IHC, IHC - Frozen, Immunofluorescence
Goat Polyclonal to Influenza Virus Influenza B Virus
Immunofluorescence, Western blot, ELISA
Influenza Virus Influenza B Virus
Influenza Virus (tested or 100% immunogen sequence identity)
Specificity and Use
Yamagata strain of Influenza B.
Recognizes influenza virus type B and does not cross react with Influenza A, Para 1-3, RSV or adenovirus. It gives negative staining in indirect immunofluorescence on uninfected monkey kidney cells. Influenza virus type B is a genus in the virus family Orthomyxoviridae, responsible for acute respiratory illnesses in humans. It varies antigenically from influenza virus types A and C and is not divided into any subtypes. The gradual evolution of Influenza virus type B occurs via a series of mutations known as antigenic drift, in the surface glycoprotein hemagglutinin (HA), enabling the virus to evade the immune system and potentially re-infect the same host. HA glycoproteins from the Influenza virus type B are included in the annually updated trivalent flu vaccine, along with the Influenza virus type A subtypes H3N2 and H1N1.